JPRN-UMIN000047011已完成未知
Real-World Clinical Effects of Semaglutide Injection in Outpatients with Type 2 Diabetes - Clinical Effects of Semaglutide Injection
Ichinomiynishi Hospital0 个研究点目标入组 60 人开始时间: 2022年3月1日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19years-old 至 91years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients with pregnancy 2.Patients with allergy 3.Patients who hospitalize over one week 4.Patients with serious gastrointestinal illness 5.Patients with cancer 6.Patients with a history of diabetic ketoacidosis and hyperglycemic crises 7.Patients with severe infection 8.Patients with high dose corticosteroid
研究者
相似试验
尚未招募
Unknown
A study on the safety and efficacy of semaglutide in obese patientsObsesity patientsJPRN-UMIN000053714Kitasato University50
进行中（未招募）
1 期
A research study on how semaglutide works in people with fatty liver disease and liver damageEUCTR2018-004484-31-DEovo Nordisk A/S69
进行中（未招募）
1 期
A research study on how semaglutide works in people with fatty liver disease and liver damageNon-alcoholic steatohepatitis Compensated liver cirrhosisMedDRA version: 20.1 Level: PT Classification code 10053219 Term: Non-alcoholic steatohepatitis System Organ Class: 10019805 - Hepatobiliary disordersMedDRA version: 20.0 Level: LLT Classification code 10024667 Term: Liver cirrhosis System Organ Class: 10019805 - Hepatobiliary disordersEUCTR2018-004484-31-ESovo Nordisk A/S69
进行中（未招募）
1 期
A research study on how semaglutide works in people with fatty liver disease and liver damageEUCTR2018-004484-31-GBovo Nordisk A/S69
进行中（未招募）
1 期
A research study on how semaglutide works in people with fatty liver disease and liver damageEUCTR2018-004484-31-FRovo Nordisk A/S71